Well I thought we were trying to crack down on hydrocodone abuse and maybe the deterrent properties are the key here.  In the last couple imageof years I seem to remember more of these types of products being approved or maybe I’m just imagining things?  It comes from Purdue labs, one of the long time manufacturers of hydrocodone.   Granted we need pain killers for short term after surgeries, etc. and some folks with long term use needed to where there’s not any other alternatives so they can’t go away.  BD 

The U.S. Food and Drug Administration today approved Hysingla ER (hydrocodone bitartrate), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Hysingla ER has approved labeling describing the product’s abuse-deterrent properties consistent with the FDA’s 2013 draft guidance for industry, Abuse-Deterrent Opioids – Evaluation and Labeling.

Hysingla ER has properties that are expected to reduce, but not totally prevent, abuse of the drug when chewed and then taken orally, or crushed and snorted or injected. The tablet is difficult to crush, break or dissolve. It also forms a viscous hydrogel (thick gel) and cannot be easily prepared for injection. The FDA has determined that the physical and chemical properties of Hysingla ER are expected to make abuse by these routes difficult. However, abuse of Hysingla ER by these routes is still possible. It is important to note that taking too much Hysingla ER, whether by intentional abuse or by accident, can cause an overdose that may result in death.



Post a Comment